Skip to main content
. 2023 May 18;10(6):ofad270. doi: 10.1093/ofid/ofad270

Table 1.

Counts, Crude Incidence Rates per 100 000 Population (95% CI), and Incidence Rate Ratios (95% CI) of (A) All GAS Infections (Invasive and Noninvasive), (B) Scarlet Fever, and (C) Invasive GAS Infections by LAIV Pilot and Nonpilot Areas and Influenza Seasons, 2010/2011 to 2016/2017 for Targeted Age Groups, 2 to 4 Years and 5 to 10 Years

Season/Pilot Type 2 to 4 Years 5 to 10 Years
Count Crude Rate per 100 000 Population (95% CI) Incidence Rate Ratio (95% CI) Count Crude Rate per 100 000 Population (95% CI) Incidence Rate Ratio (95% CI)
(A) GAS
2010/2011
Pilot 72 53.0 (41.5–66.8) 1.44 (1.13–1.84) 96 38.0 (30.8–46.4) 1.59 (1.29–1.96)
Nonpilot 667 36.8 (34.1–39.7) 784 23.9 (22.3–25.7)
2011/2012
Pilot 78 56.7 (44.8–70.8) 1.48 (1.17–1.87) 119 46.7 (38.7–55.9) 1.89 (1.56–2.30)
Nonpilot 707 38.4 (35.6–41.3) 819 24.7 (23–26.4)
2012/2013
Pilot 91 65.3 (52.6–80.2) 1.05 (0.85–1.29) 108 41.6 (34.2–50.3) 1.24 (1.01–1.50)
Nonpilot 1170 62.5 (58.9–66.1) 1144 33.7 (31.8–35.7)
2013/2014
Pilot 107 75.9 (62.2–91.8) 0.97 (0.80–1.18) 146 54.7 (46.1–64.3) 0.98 (0.83–1.16)
Nonpilot 1481 78.1 (74.2–82.2) 1952 55.7 (53.2–58.2)
2014/2015
Pilot 91 63.1 (50.8–77.5) 0.65 (0.53–0.80) 136 49.5 (41.5–58.5) 0.87 (0.73–1.04)
Nonpilot 1885 97.2 (92.8–101.7) 2043 56.7 (54.3–59.2)
2015/2016
Pilot 133 91.1 (76.3–108.0) 0.83 (0.70–1.00) 145 51.7 (43.6–60.8) 0.84 (0.71–0.99)
Nonpilot 2124 108.7 (104.1–113.4) 2282 61.7 (59.2–64.3)
(B) Scarlet Fever
2016/2017
Pilot 93 63.7 (51.4–78.0) 0.72 (0.59–0.89) 130 45.2 (37.8–53.7) 0.79 (0.67–0.95)
Nonpilot 1713 88.1 (84.0–92.4) 2158 56.9 (54.5–59.4)
2010/2011
Pilot 59 43.5 (33.1–56.1) 0.85 (0.65–1.10) 40 15.8 (11.3–21.6) 0.73 (0.53–1.01)
Nonpilot 931 51.4 (48.2–54.8) 710 21.7 (20.1–23.3)
2011/2012
Pilot 89 64.7 (52.0–79.7) 1.22 (0.98–1.52) 50 19.7 (14.6–25.9) 0.78 (0.59–1.04)
Nonpilot 976 53.0 (49.7–56.4) 833 25.1 (23.4–26.9)
2012/2013
Pilot 92 66.0 (53.2–81.0) 0.78 (0.63–0.96) 76 29.3 (23.1–36.7) 0.72 (0.57–0.90)
Nonpilot 1594 85.1 (81.0–89.4) 1390 40.9 (38.8–43.2)
2013/2014
Pilot 305 216.5 (192.8–242.2) 1.05 (0.93–1.18) 290 108.6 (96.4–121.8) 1.10 (0.98–1.24)
Nonpilot 3922 206.92 (200.5–213.5) 3447 98.3 (95.1–101.7)
2014/2015
Pilot 313 217.1 (193.7–242.5) 0.74 (0.66–0.82) 232 84.4 (73.9–96.0) 0.71 (0.62–0.81)
Nonpilot 5722 295.0 (287.4–302.7) 4297 119.3 (115.7–122.9)
2015/2016
Pilot 364 249.3 (224.4–276.3) 0.79 (0.71–0.87) 227 80.9 (70.7–92.1) 0.60 (0.53–0.69)
Nonpilot 6206 317.5 (309.6–325.5) 4980 134.7 (131.0–138.5)
2016/2017
Pilot 380 260.2 (234.7–287.7) 1.04 (0.94–1.16) 345 119.9 (107.6–133.3) 1.15 (1.03–1.28)
Nonpilot 4859 249.9 (243.0–257.1) 3966 104.6 (101.4–107.9)
(C) iGAS
2010/2011
Pilot 1 0.7 (0.0–4.1) 0.29 (0.04–2.10) 3 1.2 (0.2–3.5) 1.56 (0.47–5.16)
Nonpilot 46 2.5 (1.9–3.4) 25 0.8 (0.5–1.0)
2011/2012
Pilot 1 0.7 (0.0–4.1) 0.45 (0.06–3.28) 1 0.4 (0.0–2.2) 0.59 (0.08–4.40)
Nonpilot 30 1.6 (1.1–2.3) 22 0.7 (0.4–1.0)
2012/2013
Pilot 6 4.3 (1.6–9.4) 2.12 (0.90–5.02) 1 0.4 (0–2.2) 0.30 (0.04–2.16)
Nonpilot 38 2.0 (1.4–2.8) 44 1.3 (0.9–1.7)
2013/2014
Pilot 1 0.7 (0.0–4.0) 0.36 (0.05–2.65) 2 0.7 (0.1–2.7) 0.82 (0.20–3.42)
Nonpilot 37 2.0 (1.4–2.7) 32 0.9 (0.6–1.3)
2014/2015
Pilot 0 0.0 (0.0–2.6) 3 1.1 (0.2–3.2) 0.91 (0.28–2.95)
Nonpilot 54 2.8 (2.1–3.6) 43 1.2 (0.9–1.6)
2015/2016
Pilot 5 3.4 (1.1–8.0) 0.92 (0.37–2.27) 2 0.7 (0.1–2.6) 0.45 (0.11–1.83)
Nonpilot 73 3.7 (2.9–4.7) 59 1.6 (1.2–2.1)
2016/2017
Pilot 3 2.1 (0.4–6.0) 0.71 (0.22–2.28) 3 1.0 (0.2–3.1) 1.24 (0.38–4.04)
Nonpilot 56 2.9 (2.2–3.7) 32 0.8 (0.6–1.2)

Significant IRRs with P values <.05 are highlighted in bold.

Abbreviations: GAS, group A Streptococcus; iGAS, invasive group A Streptococcus; IRR, incidence rate ratio.